Summary
Human T-cell leukemia/lymphoma virus type I (HTLV-I) is the cause of adult T-cell leukemia/lymphoma (ATL) and a chronic neurologic syndrome It occurs worldwide but with clusters of high seroprevalence in Japan, Africa, and the Caribbean. A related virus known as HTLV-II occurs in endemic clusters in New World Indian populations and is very common among intravenous drug users in some regions. HTLV-II accounts for about half of all HTLV seropositivity in the USA. HTLV-II is not known to be a pathogen Serologic reagents for the detection of these viruses, made from lysates of HTLV-I-infected cells, are believed to be very sensitive to HTLV-I infection Their sensitivity to HTLV-II is largely unknown. Highly sensitive polymerase chain reaction (PCR) detection systems are available and are particularly useful for the evaluation of sérologie tests, for distinguishing HTLV-I from HTLV-II, for determining whether or not infection is present in patients with incomplete or absent seroreactivity or in the obligately seropositive children of seropositive mothers.
Serologic reagents for the detection of these viruses, made from lysates of HILV-I-infected cells, are believed to be very sensitive to HTLV-I infection Their sensitivity to HTLV-II is largely unknown. Highly sensitive polymerase chain reaction (PCR) detection systems are available and are particularly useful for the evaluation of serologic tests, for distinguishing HTLV-I from HTLV-II, for determining whether or not infection is present in patients with incomplete or absent seroreactivity or in the obligately seropositive children of seropositive mothers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blattner WA, Takatsuki K, Gallo RC (1983) Human T-cell leukemia-lymphoma virus and adult T-cell leukemia. JAMA 250:51–58
Daenke S, Nightingale S, Cruickshank JK, Bangham CRM (1990) Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol 64:1278–1282
DeFreitas E, Hilliard B, Cheney PR, Bell DS, Kiggundu E, Sankey D, Wroblewska Z, Palladino M, Woodward JP, Koprowski H (1991) Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci USA 88:2922–2926
Donegan E, Busch MP, Galleshaw JA et al. (1990) Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. Ann Intern Med 113:555–556
Gessain A, Vernant JC, Maurs L, Barin F, Gout O, Calender A, de The G (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407–409
Gray GS, White M, Bartman T, Mann D (1990) Envelope gene sequence of HTLV-1 isolate MT-2 and its comparison with other HTLV-1 isolates. Virology 177:391–395
Heneine W, Kaplan JE, Gracia F, Lal R, Roberts B, Levine PH, Reeves WC (1991) HTLV-II endemicity among Guaymi Indians in Panama. N Engl J Med 324:565
Hino S (1990) Maternal-infant transmission of HTLV-I: implications for disease. In: Blattner WA (ed) Human retrovirology: HTLV Raven, New York, pp 363–375
Hinuma Y (1985) A retro virus associated with a human leukemia, adult T-cell leukemia. Curr Top Microbiol Immunol 115:127–141
Hjelle B (1991) Human T-cell leukemia/lymphoma viruses: life cycle, pathogenicity, epidemiology and diagnosis. Arch Pathol Lab Med 115:440–450
Hjelle B, Chaney R (1992) Sequence variation of functional HTLV-II tax alleles among isolates from an endemic population: Lack of evidence for oncogenic determinant in tax. J Med Virol 36:136–141
Hjelle B, Mills R, Mertz G, Swenson S (1990 a) Transmission of HTLV-II by transfusion. Vox Sang 59:119–122
Hjelle B, Scalf R, Swenson S (1990 b) High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. Blood 76:450–454
Hjelle B, Mills R, Swenson S, Mertz G, Key C, Allen S (1991) Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis 163:435–440
Kalyanramen VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Blayney D, Golde DW, Gallo RC (1982) A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218:571–573
Komurian F, Pelloquin F, de The G (1991) In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol 65:3770–3778
Kwok S, Higuchi R (1989) Avoiding false positives with PCR. Nature 339:237–238
Kwok S, Kellogg D, Ehrlich G, Poiesz B, Bhagavati S, Sninsky JJ (1988) Characterization of a sequence of human T cell leukemia virus type I from a patient with chronic progressive myelopathy. J Infect Dis 158:1193–1197
Lairmore MD, Jacobson S, Gracia F, De BK, Castillo L, Larreategui M, Roberts BD, Levine PH, Blattner WA, Kaplan JE (1990) Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA 87:8840–8844
Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen ISY (1989) High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 244:471–475
LeGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W (1990) Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 336:1345–1347
Lillehoj EP, Alexander SS, Dubrule CJ, Wiktor S, Adams R, Tai C-C, Manns A, Blattner WA (1990) Development and evaluation of a human T-cell leukemia virus type I sérologic confirmatory assay incorporating a recombinant envelope polypeptide. J Clin Microbiol 28:2653–2658
Malik KT, Even J, Karpas A (1988) Molecular cloning and complete nucleotide sequence of an adult T cell leukaemia virus/human T cell leukaemia virus type I (ATLV/HTLV-I isolate of Caribbean origin: relationship to other members of the ATLV/HTLV-I subgroup). J Gen Virol 69:1695–1710
Matsumoto C, Mitsunaga S, Oguchi T, Mitomi Y, Shimada T, Ichikawa A, Watanabe J, Nishioka K (1990) Detection of human T-cell leukemia virus type I (HTLV-I) provirus in an infected cell line and in peripheral mononuclear cell of blood donors by the nested polymerase chain reaction method: comparison with HTLV-I antibody tests. J Virol 64:5290–5294
Miyoshi I, Kubinishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y (1981) Type-C virus particles in a cord T-cell line derived by cocultivation of normal human cord leukocytes and human leukemic T-cells. Nature 294:770–771
Morgan OSTC, Mora C, Rodgers-Johnson P, Char G (1989) HTLV-I and polymyositis in Jamaica. Lancet 2:1184–1187
Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031–1032
Poiesz BJ, Ruscetti FW, Gadzar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415–7419
Ratner L, Josephs SF, Starcich B, Hahn B, Shaw GM, Gallo RC, Wong-Staal F (1985) Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-I b) provirus with a deletion in pX-L. J Virol 54:781–790
Rosenblatt JD, Golde DW, Wachsman W, Jacobs A, Schmidt G, Quan S, Gasson JC, Chen ISY (1986) A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med 313:372–377
Rosenblatt JD, Gasson JC, Glaspy J, Bhuta S, Abud M, Chen ISY, Golde DW (1987) Relationship between human T-cell leukemia virus-II and atypical hairy cell leukemia: a sérologie study of hairy cell leukemia patients. Leukemia 1:397–401
Rosenblatt JD, Plaeger-Marshall S, Giorgi JV, Swanson P, Chen ISY, Chin E, Wang H, Canavaggio M, Black AC, Lee H (1990) A clinical, hématologie, and immunologic analysis of 21 HTLV-II-infected intravenous drug users. Blood 76:409–417
Rous P (1910) A transmissable avian neoplasm: sarcoma of the common fowl. J Exp Med 12:696–705
Ruano G, Fenton W, Kidd KK (1989) 13. phasic amplification of very dilute DNA samples via ‘booster’. PCR Nucl Acids Res 17:5407–5415
Sciki M, Eddy R, Shows TB, Yoshida M (1984) Nonspecific integration of the HTLV provirus into adult T-cell leukemia cells. Nature 309:640–642
Tsujimoto A, Teruuchi T, Imamura J, Shimotohno K, Miyoshi I, Miwa M (1988) Nucleotide sequence analysis of a provirus derived from HTLV-1-associated myelopathy (HAM). Mol Biol Med 5:29–42
Wiktor SZ, Alexander SS, Shaw GM, Weiss SH, Murphy L, Wilks RJ, Shortly VJ, Hanchard B, Blattner WA (1990) Distinguishing between HTLV-I and HTLV-II by Western blot. Lancet 335:1533
Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213–222
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hjelle, B. (1992). Detection of Human T-cell Leukemia Viruses. In: Becker, Y., Darai, G. (eds) Diagnosis of Human Viruses by Polymerase Chain Reaction Technology. Frontiers of Virology, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84766-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-84766-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84768-4
Online ISBN: 978-3-642-84766-0
eBook Packages: Springer Book Archive